First Trust Advisors LP Fibrogen Inc Transaction History

First Trust Advisors LP

$101 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.49 - $20.59 $504,361 - $4.17 Million	-202,555 Reduced 7.44%	2,518,420 $6.8 Million
Q1 2023 May 15, 2023	SELL	$15.95 - $25.18 $4.06 Million - $6.41 Million	-254,678 Reduced 8.56%	2,720,975 $50.8 Million
Q4 2022 Feb 09, 2023	SELL	$13.27 - $17.73 $8.63 Million - $11.5 Million	-650,483 Reduced 17.94%	2,975,653 $47.7 Million
Q3 2022 Nov 14, 2022	SELL	$11.4 - $14.6 $5.21 Million - $6.67 Million	-456,826 Reduced 11.19%	3,626,136 $47.2 Million
Q2 2022 Aug 12, 2022	BUY	$7.94 - $12.96 $4.8 Million - $7.83 Million	603,975 Added 17.36%	4,082,962 $43.1 Million
Q1 2022 May 13, 2022	SELL	$12.02 - $16.79 $22.1 Million - $30.9 Million	-1,838,626 Reduced 34.58%	3,478,987 $41.8 Million
Q4 2021 Feb 08, 2022	BUY	$9.93 - $15.39 $10.5 Million - $16.2 Million	1,055,536 Added 24.77%	5,317,613 $75 Million
Q3 2021 Nov 15, 2021	BUY	$10.18 - $26.64 $11.8 Million - $30.8 Million	1,155,245 Added 37.18%	4,262,077 $43.6 Million
Q2 2021 Aug 16, 2021	BUY	$18.57 - $35.68 $27.4 Million - $52.7 Million	1,477,214 Added 90.65%	3,106,832 $82.7 Million
Q1 2021 May 14, 2021	BUY	$31.0 - $55.72 $6.58 Million - $11.8 Million	212,144 Added 14.97%	1,629,618 $56.6 Million
Q4 2020 Feb 02, 2021	SELL	$37.09 - $48.97 $9.38 Million - $12.4 Million	-252,968 Reduced 15.14%	1,417,474 $52.6 Million
Q3 2020 Nov 05, 2020	SELL	$40.47 - $45.5 $579,247 - $651,241	-14,313 Reduced 0.85%	1,670,442 $68.7 Million
Q2 2020 Jul 22, 2020	BUY	$32.57 - $42.83 $12 Million - $15.7 Million	366,944 Added 27.84%	1,684,755 $68.3 Million
Q1 2020 May 06, 2020	BUY	$23.3 - $45.96 $247,539 - $488,279	10,624 Added 0.81%	1,317,811 $45.8 Million
Q4 2019 Feb 03, 2020	SELL	$34.58 - $48.06 $107,509 - $149,418	-3,109 Reduced 0.24%	1,307,187 $56.1 Million
Q3 2019 Nov 04, 2019	SELL	$36.98 - $48.45 $27.2 Million - $35.7 Million	-735,896 Reduced 35.96%	1,310,296 $48.5 Million
Q2 2019 Jul 30, 2019	BUY	$35.13 - $55.53 $5.12 Million - $8.09 Million	145,732 Added 7.67%	2,046,192 $92.4 Million
Q1 2019 May 09, 2019	BUY	$42.83 - $59.91 $8.27 Million - $11.6 Million	193,038 Added 11.31%	1,900,460 $103 Million
Q4 2018 Feb 07, 2019	BUY	$37.97 - $60.16 $2.1 Million - $3.32 Million	55,209 Added 3.34%	1,707,422 $79 Million
Q3 2018 Oct 25, 2018	BUY	$56.3 - $67.25 $25.5 Million - $30.5 Million	453,288 Added 37.81%	1,652,213 $100 Million
Q2 2018 Aug 02, 2018	BUY	$44.9 - $64.95 $8.74 Million - $12.7 Million	194,766 Added 19.4%	1,198,925 $75.1 Million
Q1 2018 Apr 23, 2018	BUY	$45.35 - $61.65 $10.3 Million - $14 Million	227,519 Added 29.3%	1,004,159 $46.4 Million
Q4 2017 Feb 08, 2018	BUY	$41.95 - $60.1 $29.8 Million - $42.6 Million	709,598 Added 1058.44%	776,640 $36.8 Million
Q3 2017 Oct 24, 2017	BUY	$33.4 - $53.9 $2.24 Million - $3.61 Million	67,042	67,042 $3.61 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

Primecap Management CO Pasadena, CA

9.91M
Shares

$3.47 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

6.8M
Shares

$2.38 Million
0.05% of portfolio
Vanguard Group Inc Valley Forge, PA

5.88M
Shares

$2.06 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.91M
Shares

$1.37 Million
0.0% of portfolio
Black Rock Inc. New York, NY

2.41M
Shares

$843,377
0.0% of portfolio

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Account